Influence of allopurinol on evoked cortical afterdischarges during early ontogenesis

Physiological Research

Volumn 61, Issue SUPPL.2, 2012, Pages

  Jandova K ^a   Riljak, V ^a   Pokorny J ^a   Maresova D ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Allopurinol; Development; Evoked potentials; Hypoxia; Rat

Indexed keywords

ALLOPURINOL;

ANIMAL; ARTICLE; BRAIN; BRAIN HYPOXIA; DRUG EFFECT; ELECTROSTIMULATION; MALE; NEWBORN; PATHOPHYSIOLOGY; RAT; WISTAR RAT;

ALLOPURINOL; ANIMALS; ANIMALS, NEWBORN; BRAIN; ELECTRIC STIMULATION; HYPOXIA, BRAIN; MALE; RATS; RATS, WISTAR;

EID: 84873152186     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. AKDEMIR H, AŞIK Z, PAŞAOǦLU H, KARAKÜÇÜK I, OKTEM IS, KOÇ RK. The effect of allopurinol on focal cerebral ischaemia: an experimental study in rabbits. Neurosurg Rev 24: 131-135, 2001.
2. AKHONDZADEH S, SAFARCHERATI A, AMINI H. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 29: 253-259, 2005.
3. BERGER R, GARNIER Y. Pathophysiology of perinatal brain damage. Brain Res Brain Res Rev 30: 107-134, 1999.
4. BIDMON HJ, EMDE B, KOWALSKI T, SCHMITT M, MAYER B, KATO K, ASAYAMA K, WITTE OW, ZILLES K. Nitric oxide synthase-I containing cortical interneurons co-express antioxidative enzymes and antiapoptotic Bcl-2 following focal ischemia: evidence for direct and indirect mechanisms towards their resistance to neuropathology. J Chem Neuroanat 22: 167-184, 2001.
5. BUONOCORE G, GROENENDAAL F. Anti-oxidant strategies. Semin Fetal Neonatal Med 12: 287-295, 2007.
6. COWAN F, RUTHERFORD M, GROENENDAAL F, EKEN P, MERCURI E, BYDDER GM, MEINERS LC, DUBOWITZ LM, DE VRIES LS. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet 361: 736-742, 2003.
7. DAS DK, ENGELMAN RM, CLEMENT R, OTANI H, PRASAD MR, RAO PS. Role of xantine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun 148: 314-319, 1987.
8. DAY RO, GRAHAM GG, HICKS M, MCLACHLAN AJ, STOCKER SL, WILLIAMS KM. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol. Clin Pharmacokinet 46: 623-644, 2007.
9. DOBLE A. The role of excitotoxicity in neurodegenerative disease: implications in therapy. Pharmacol Ther 81: 163-221, 1999.
10. GOLAN H, HULEIHEL M. The effect of prenatal hypoxia on brain development: short- and long-term consequences demonstrated in rodent models. Dev Sci 27: 338-349, 2006.
11. GROENENDAAL F, DE GRAAF RA, VAN VLIET G, NICOLAY K. Effects of hypoxia-ischemia and inhibition of nitric oxide synthase on cerebral energy metabolism in newborn piglets. Pediatr Res 45: 827-833, 1999.
12. ITOH T, KAWAKAMI M, YAMAUCHI Y, SHIMIZU S, NAKAMURA M. Effect of allopurinol on ischemia and reperfusion-induced cerebral injury in spontaneously hypertensive rats. Stroke 17: 1284-1287, 1986.
13. KALINCIK T, MARESOVÁ D. Influence of magnesium sulphate on evoked activity of rat brain after exposure to short-term hypoxia. Physiol Res 54: 229-234, 2005.
14. KELEN D, ROBERTSON NJ. Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum Dev 86: 369-377, 2010.
15. KO KM, GODIN DV. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem Pharmacol 40: 803-809, 1990.
16. LIPTON P. Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1568, 1999.
17. MARES P, KUBOVÁ H. What is the role of neurotransmitter systems in corticalseizures? Physiol Res 57: 111-120, 2008.
18. MARESOVÁ D, VALKOUNOVÁ I, JANDOVÁ K, BORTELOVÁ J, TROJAN S. Excitability changes of cortical neurons during the postnatal period in rats exposed to prenatal hypobaric hypoxia. Physiol Res 50: 215-219, 2001.
19. MINK RB, DUTKA AJ, HALLENBECK JM. Allopurinol pretreatment improves evoked response recovery following global cerebral ischemia in dogs. Stroke 22: 660-665, 1991.
20. MORI A, HIRAMATSU M, YOKOI I, EDAMATSU R. Biochemical pathogenesis of post-traumatic epilepsy. Pavlov J Biol Sci 25: 54-62, 1990.
21. MURASHIMA YL, KASAMO K, SUZUKI J. Antiepileptic effects of allopurinol on EL mice are associated with changes in SOD isoenzyme activities. Epilepsy Res 32: 254-265, 1998.
22. NYAKAS C, BUWALDA B, LUITEN PG. Hypoxia and brain development. Prog Neurobiol 49: 1-51, 1999.
23. PALMER C, VANNUCCI RC, TOWFIGHI J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 27: 332-336, 1990.
24. PETERSON DA, KELLY B, GERRARD JM. Allopurinol can act as an electron transfer agent. Is this relevant during reperfusion injury? Biochem Biophys Res Commun 137: 76-79, 1986.
25. SAUGSTAD OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 98: 103-107, 1996.
26. SCHWARTZKROIN PA, KNOWLES WD. Intracellular study of human epileptic cortex: in vitro maintenance of epileptiform activity? Science 223: 709-712, 1984.
27. SIESJÖ BK, AGARDH CD, BENGTSSON F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1: 165-211, 1989.
28. TADA H, MOROOKA K, ARIMOTO K, MATSUO T. Clinical effects of allopurinol on intractable epilepsy. Epilepsia 32: 279-283, 1991.
29. VANNUCCI RC, VANNUCCI SJ. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci 27: 81-86, 2005.
30. WADA Y, HASEGAWA H, NAKAMURA M, YAMAGUCHI N. Anticonvulsant effect of allopurinol on hippocampal-kindled seizures. Pharmacol Biochem Behav 42: 899-901, 1992.
31. WALDBAUM S, PATEL M. Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy? J Bioenerg Biomembr 42: 449-455, 2010.